Latest News

Dr. Nicholas G. Nickols, an attending physician at the West LA VA and assistant professor of radiation oncology at the David School of Medicine, has been awarded the prestigious 2017 VALOR Young Investigator Award by the Prostate Cancer Foundation.

July 19, 2017 6:00 AM

As of July 1, 2017 Dr. Patricia Ganz will assume editorial leadership of one of the oldest and most internationally respected oncology journals, JNCI: Journal of the National Cancer Institute.

July 05, 2017 9:00 AM

Dr. Mark Litwin discusses his new review of the diagnosis and treatment of prostate cancer in JAMA, and how he assesses the optimal methods for the diagnosis and treatment of prostate cancer based on current evidence.

July 03, 2017 10:00 AM

Did you know grilling can increase your risk for cancer? Don't worry, our own Dr. Catherine Carpenter, professor of clinical nutrition, has some healthy tips to keep your summer barbecue lit!

June 30, 2017 1:00 PM

Cancer survivor Sheila Henry spent 18 years raising money for cancer research at the Jonsson Cancer Center Foundation at UCLA and UCLA Health. Watch her story on KCAL 9 and CBS Los Angeles.

June 29, 2017 12:00 PM

Dr. Michael Steinberg, Director of Clinical Affairs at UCLA’s Jonsson Comprehensive Cancer Center, and professor and chair of the Department of Radiation Oncology at the David Geffen School of Medicine, has received the American Society for Radiation Oncology (ASTRO) 2017 Gold Medal for his outstanding lifetime contributions in the field of radiation oncology.

June 27, 2017 10:00 AM

A non-profit organization focused on raising money for childhood cancer research has awarded Dr. Julia Heck, associate research professor of epidemiology in the UCLA Fielding School of Public Health, with a two-year, $200,000 grant to study pediatric cancer in Taiwan.

June 14, 2017 8:00 AM

After her second diagnosis with cancer, Lila Javan had to put her dream of climbing Mt. Kilimanjaro on hold. But that didn't stop her from eventually reaching the peak, and this time she was able to bring along a special group of friends including her oncologist, UCLA's Dr. Sarah Larson.

June 04, 2017 6:00 AM

Scientists with UCLA’s Jonsson Comprehensive Cancer Center will present some of the most highly anticipated research at the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO). The event takes place at the McCormick Convention Center in Chicago from June 2 through June 6.

June 01, 2017 9:00 AM

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

May 25, 2017 6:30 AM

If you have had insomnia, you know worrying about sleep makes it even harder to fall asleep. For the 30 percent of breast cancer survivors who have insomnia, sleepless nights can lead to depression, fatigue and a heightened risk of disease.

May 15, 2017 9:00 AM

UCLA scientists have discovered a dendritic cell vaccine that amplifies the response of the immune system in people with non-small cell lung cancer, the most common form of lung cancer.

May 11, 2017 9:00 AM

Celebrating its 22nd year, the UCLA Jonsson Cancer Center Foundation’s signature event, Taste for a Cure, was held on Friday, April 28 at the Beverly Wilshire Hotel. During this special evening, Yael and Scooter Braun were honored with the 2017 Gil Nickel Humanitarian Award, presented by James Corden.

May 09, 2017 10:00 AM

A new study by scientists at the UCLA Jonsson Comprehensive Cancer Center could be a significant step toward understanding how certain cases of advanced melanoma shield themselves from pembrolizumab, the FDA-approved treatment that harnesses the immune system to attack the disease.

May 09, 2017 9:00 AM

Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.

May 04, 2017 11:30 AM

UCLA researcher Dr. Siwen Hu-Lieskovan has been awarded the Phillip A. Sharp Innovation in Collaboration Award from Stand Up To Cancer (SU2C) to fund her work using genomics to better understand how melanoma and other cancers can become resistant to immunotherapy.

May 03, 2017 12:00 PM

Dr. Jacqueline Casillas, clinical director of UCLA’s Pediatric Cancer Survivorship Program and associate director of the UCLA-LIVESTRONG Survivorship Center of Excellence, has received the 2017 Unmasque “Caregiver” Award from the The Samfund organization for her decades-long commitment to young pediatric cancer survivorship.

May 01, 2017 8:00 AM

The U.S. Food & Drug Administration today approved a new drug to treat people with hepatocellular carcinoma, the most common form of liver cancer. The drug, regorafenib, is the first and only therapy approved by the FDA in over a decade to show significant improvement in survival for patients with the disease after standard treatments have failed.

April 27, 2017 1:00 PM

In 2015, Denise Delatorre was diagnosed with aggressive lymphoma. Chemotherapy failed to work. She was given six months to live. But the Laguna Beach mother read about a study at UCLA involving a unique immunotherapy called CAR-T cell therapy. She became the first patient to be involved in the clinical trial.

April 26, 2017 10:00 AM